IREDEX Ophthalmology Revenues Up to $9.2M in 4Q

IREDEX, laser-based medical systems developer and manufacturer, has announced that its ophthalmology revenues in the fourth quarter of 2012 were $9.2 million, up from $8.6 million in the fourth quarter of 2011, a nearly 7 percent increase, according to a Daily Markets report.

Advertisement

Ophthalmology revenues in the fourth quarter of 2012 were a record high for the Mountain View, Calif.-based IREDEX.

More Articles on Ophthalmology:
NY Vision Group Opens Tribeca Location
Transcend Medical Joins COMPASS Clinical Study to Assess CyPass Micro-Stent
Ocular Therapeutix Seeking FDA Approval for ReSure Sealant

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.